Results 161 to 170 of about 31,914 (284)

Novel oral anticoagulants for the prevention of thromboembolism in patients with atrial fibrillation

, 2013
The most significant complication of atrial fibrillation (AF) is thromboembolic stroke. Furthermore, the consequences of AF-related stroke tend to be more severe than those of other aetiologies.
Connelly, D.T., Lang, N.N.
core   +1 more source

Association of Intracerebral Hemorrhage Among Patients Taking Non–Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality

Journal of the American Medical Association (JAMA), 2018
T. Inohara, Y. Xian, L. Liang, Roland A. Matsouaka, J. Saver, Eric E. Smith, L. Schwamm, M. Reeves, Adrian F. Hernandez, Deepak L. Bhatt, E. Peterson, G. Fonarow   +11 more
semanticscholar   +1 more source

Non–Vitamin K Antagonist Versus Vitamin K Antagonist Oral Anticoagulant Agents After Transcatheter Aortic Valve Replacement

JACC: Cardiovascular Interventions
Studies comparing long-term outcomes between non-vitamin K antagonist (VKA) oral anticoagulant agents (direct oral anticoagulant agents [DOACs]) and VKA anticoagulant agents after transcatheter aortic valve replacement (TAVR) are scarce, with conflicting results.The aim of this study was to examine the periprocedural, short-term, and long-term safety ...
Alaour, Bashir, Ferrari, Enrico, Heg, Dik, Tueller, David, Pilgrim, Thomas, Muller, Olivier, Noble, Stéphane Laurent, Jeger, Raban, Reuthebuch, Oliver, Toggweiler, Stefan, Templin, Christian, Wenaweser, Peter, Nietlispach, Fabian, Taramasso, Maurizio, Huber, Christoph, Roffi, Marco, Windecker, Stephan, Stortecky, Stefan   +17 more
openaire   +3 more sources

Laboratory Identification of Lupus Anticoagulant (LA) Using Different Activated Partial Thromboplastin Time (APTT) Assays

International Journal of Laboratory Hematology, Volume 48, Issue 1, Page 172-178, February 2026.
ABSTRACT Introduction The International Society of Thrombosis and Hemostasis (ISTH) guidelines suggest a three‐step evaluation for the detection of lupus anticoagulant (LA), including screening, mixing, and confirmation. According to the guidelines, the LA assay based on activated partial thromboplastin time (APTT) should include an initial screening ...
Bárbara G. Barion, Bianca Stefanello, Maria Luiza S. A. de Paula, Thaís S. Saraiva, Paula R. Villaça, Vanderson Rocha, Fernanda A. Orsi, Tania R. F. da Rocha   +7 more
wiley   +1 more source

Real-world national trends and influencing factors preference of non-vitamin K antagonist oral anticoagulants in China. [PDF]

Front Med (Lausanne), 2023
Zhu S, Li M, Wang L, Hou L, Li D, Liu J, Lu Y.   +6 more
europepmc   +1 more source

Dabigatrán fronte acenocumarol ou warfarina en pacientes con fibrilación auricular [PDF]

, 2018
[Resumo] Introdución: A fibrilación auricular non valvular (FANV) é a arritmia máis frecuente e o ictus a súa principal complicación. Nos pacientes con alto risco de embolización, a terapia anticoagulante demostrou ser altamente eficaz. Os antagonistas
García Costa, Noelia
core  

Inflammatory and Myocardial Biomarker Response Following Pulmonary Vein Isolation: Cryoballoon Versus Balloon‐in‐Basket Pulsed Field Ablation

Journal of Cardiovascular Electrophysiology, Volume 37, Issue 2, Page 296-304, February 2026.
ABSTRACT Background Cryoballoon ablation (CB) is a well‐established thermal technique for pulmonary vein isolation (PVI), while balloon‐in‐basket pulsed field ablation (BiB‐PFA) represents a novel non‐thermal alternative. Both single‐shot systems may trigger systemic inflammation and myocardial injury, yet direct comparisons are lacking.
Jan‐Per Wenzel, Sascha Hatahet, Charlotte Eitel, Raed Abdessadok, Sorin Popescu, Julius Nikorowitsch, Suzanne de Waha, Tanja Zeller, Karl‐Heinz Kuck, Roland Richard Tilz   +9 more
wiley   +1 more source

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary.

Europace, 2018
J. Steffel, P. Verhamme, T. Potpara, P. Albaladéjo, M. Antz, L. Desteghe, Karl Georg Haeusler, J. Oldgren, H. Reinecke, V. Roldán-Schilling, N. Rowell, P. Sinnaeve, R. Collins, A. Camm, H. Heidbüchel, G. Lip, J. Weitz, L. Fauchier, D. Lane, G. Boriani, A. Goette, R. Keegan, R. Macfadyen, C. Chiang, B. Joung, W. Shimizu   +25 more
semanticscholar   +1 more source

Predictors of Atrial High‐Rate Episodes and Inappropriate Device Therapy in Implantable Cardioverter Defibrillators

Pacing and Clinical Electrophysiology, Volume 49, Issue 2, Page 71-81, February 2026.
ABSTRACT Background Implantable cardioverter defibrillator (ICD) therapy can prevent sudden cardiac death, but poses a risk of inappropriate device therapy (IDT), which is linked to worse outcomes and reduced quality of life. On the other hand, ICDs can function as an early warning system for atrial arrhythmias.
Marthe J. Huntelaar, Luuk H. G. A. Hopman, Anne‐Lotte C. J. van der Lingen, Mischa T. Rijnierse, Michiel J. B. Kemme, Cornelis P. Allaart, Vokko P. van Halm   +6 more
wiley   +1 more source

Ex Vivo Antiplatelet Effects of Oral Anticoagulants

Journal of Cardiovascular Development and Disease
Background: The impact of non-vitamin K antagonist oral anticoagulants (NOACs) on platelet function is still unclear. We conducted a comprehensive ex vivo study aimed at assessing the effect of the four currently marketed NOACs on platelet function ...
Giulia Renda, Valentina Bucciarelli, Giulia Barbieri, Paola Lanuti, Martina Berteotti, Gelsomina Malatesta, Francesca Cesari, Tanya Salvatore, Betti Giusti, Anna Maria Gori, Rossella Marcucci, Raffaele De Caterina   +11 more
doaj   +1 more source